Maria Herran
Overview
Explore the profile of Maria Herran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabbagh S, Jabbal I, Herran M, Mohanna M, Iska S, Itani M, et al.
Sci Rep
. 2025 Jan;
15(1):2816.
PMID: 39843914
No consensus exists on the optimal therapy for resectable gastric cancer (GC) and gastroesophageal junction (GEJ) tumors, including the effectiveness of chemoradiotherapy versus perioperative chemotherapy (PC). Our study aimed to...
2.
Sabbagh S, Herran M, Hijazi A, Jabbal I, Mohanna M, Dominguez B, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2419142.
PMID: 38967928
Importance: Among patients with metastatic colorectal cancer (mCRC), data are limited on disparate biomarker testing and its association with clinical outcomes on a national scale. Objective: To evaluate the socioeconomic...
3.
Hijazi A, Mohanna M, Sabbagh S, Herran M, Dominguez B, Sarna K, et al.
Breast Cancer Res Treat
. 2024 Apr;
206(3):527-541.
PMID: 38683296
Purpose: Patients with Breast Cancer (BC) with Brain Metastasis (BCBM) have poor survival outcomes. We aimed to explore the clinico-pathologic and therapeutic factors predicting the survival in patients with de...
4.
Mohanna M, Herran M, Dominguez B, Sabbagh S, Msheik A, Itani M, et al.
Support Care Cancer
. 2024 Mar;
32(4):236.
PMID: 38506939
Purpose: Disparities in cancer care have been exacerbated by the COVID-19 pandemic. The aim of this study is to establish how telehealth mitigated the effect of COVID-19 on the healthcare...
5.
Camacho-Dominguez L, Rojas M, Herran M, Rodriguez Y, Beltran S, Galindo P, et al.
BMJ Open
. 2024 Feb;
14(2):e072784.
PMID: 38355186
Background: A paucity of predictive models assessing risk factors for COVID-19 mortality that extend beyond age and gender in Latino population is evident in the current academic literature. Objectives: To...
6.
Rojas M, Herran M, Ramirez-Santana C, Leung P, Anaya J, Ridgway W, et al.
J Autoimmun
. 2023 Jun;
139:103070.
PMID: 37390745
Infectious diseases are commonly implicated as potential initiators of autoimmune diseases (ADs) and represent the most commonly known factor in the development of autoimmunity in susceptible individuals. Epidemiological data and...
7.
Herran M, Adler B, Perin J, Morales W, Pimentel M, McMahan Z
Arthritis Care Res (Hoboken)
. 2023 Mar;
75(10):2166-2173.
PMID: 36951252
Objective: The gastrointestinal (GI) tract is commonly affected in systemic sclerosis (SSc). A positive association between antivinculin antibody levels and GI symptom severity is reported in SSc. We sought to...
8.
Anaya J, Herran M, Beltran S, Rojas M
Expert Rev Clin Immunol
. 2022 Jun;
18(7):653-666.
PMID: 35658801
Introduction: Post-COVID syndrome (PCS) is recognized as a new entity in the context of SARS-CoV-2 infection. Though its pathogenesis is not completely understood, persistent inflammation from acute illness and the...
9.
Botello A, Herran M, Salcedo V, Rodriguez Y, Anaya J, Rojas M
Clin Endocrinol (Oxf)
. 2020 Aug;
93(4):375-389.
PMID: 32738825
Background: Thyroid autoimmunity is the most frequent condition involved in polyautoimmunity (PolyA). However, the frequency of latent and overt PolyA in patients with autoimmune thyroid disease (AITD) as the index...